Belpointe Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $940K | Buy |
|
|||||
|
2025
Q1 | $735K | Buy |
|
|||||
|
2024
Q4 | $751K | Sell |
|
|||||
|
2024
Q3 | $1.35M | Buy |
|
|||||
|
2024
Q2 | $440K | Buy |
|
|||||
|
2024
Q1 | $381K | Buy |
|
|||||
|
2023
Q4 | $234K | Buy |
|
|||||
|
2023
Q3 | $203K | Sell |
|
|||||
|
2023
Q2 | $280K | Sell |
|
|||||
|
2023
Q1 | $603K | Buy |
|
|||||
|
2022
Q4 | $427K | Sell |
|
|||||
|
2022
Q3 | $318K | Buy |
|
|||||
|
2022
Q2 | $176K | Buy |
|
|||||
|
2022
Q1 | $129K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $111K | Buy |
|